Rong Fu

机构：Tianjin Normal University, Tianjin University, Tianjin Medical University General Hospital

发表论文 15 篇 · 总被引 125 次 · h-index 5

代表论文

• A novel histone deacetylase inhibitor Chidamide induces G0/G1 arrest and apoptosis in myelodysplastic syndromes (2016 · Biomedicine & Pharmacotherapy · 被引 42)
• The potential diagnostic power of CD138+ microparticles from the plasma analysis for multiple myeloma clinical monitoring (2019 · Hematological Oncology · 被引 35)
• Everolimus Shows Synergistic Antimyeloma Effects with Bortezomib via the AKT/mTOR Pathway (2018 · Journal of Investigative Medicine · 被引 16)
• The shortening telomere length of T lymphocytes maybe associated with hyper‑function in servere aplastic anemia (2017 · Molecular Medicine Reports · 被引 13)
• Real-world analysis of treatment patterns, effectiveness, and safety of daratumumab-based regimens in Chinese patients with newly diagnosed or relapsed/refractory multiple myeloma (2025 · BMC Cancer · 被引 5)
• Weekly Selinexor, Bortizomib and Dexamethasone (SVd) Versus Twice Weekly Bortizomib and Dexamethasone (Vd) in Chinese Patients with Relapsed and Refractory Multiple Myeloma (RRMM): Primary Analysis of Phase 3 Bench Study (2024 · Blood · 被引 5)